Abstract
An increased incidence of Candida infection has been documented during the last decade and fungi have appeared as significant nosocomial pathogens in intensive care. Disseminated candidiasis is no longer characteristic only for patients undergoing immunosuppressive therapy. In the European Prevalence of Infection in Intensive Care (EPIC) study, fungal isolates were found in 17% of patients, and 50% were treated with antifungal therapy [1]. Infections in intensive care unit (ICU) patients, however, are predominantly endogenous, and candidiasis accounts for nearly 80% of these infections and for — 10% of positive blood cultures. Candida spp. is the fifth most common microorganism found in blood cultures and the seventh most common pathogen in nosocomial infection [2–4].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Vincent, JL, Bihari DJ, Suter PM, et al (1995) The prevalence of nosocomial infection in intensive care units in Europe: Results of the European prevalence of infection in Intensive care (EPIC) study, JAMA 274:639–644
Schaberg DR, Culver DH, Gaynes RP (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med 91: S72–S75
Beck-Sague CM, Jarvis W (1993) Secular trends in the epidemiology of noscomial fungal infections in the United States, 1980–1990. J Infect Dis 167:1247–1251
Benerjee SN, Emori TG, Culver DH, et al (1991) Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1990. Am J Med 91: S86–S89
Rocco TR, Reinert SE, Simms HH (2000) Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance. Arch Surg 135:160–165
Sonneborn A, Bockmuhl DP, Gerads M, Kurpanek K, Sandlard D, Ernst JF (2000) Protein kinase A encoded by TPK2 regulates dimorphism of Candida albicans. Mol Microbiol 35:386–396
Ghannoum MA (2000) Potential role of phospholipases in virulence of and fungal pathogenesis. Clin Microbiol Rev 13:122–143
Munoz P, Burillo A, Bouza E (2000) Criteria used when initiating antifungal therapy angainst Candida spp. in the intensive care unit. Int J Antimicrob Agents 15:83–90
Way SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1998) Hospital acquired candidemia: the attributable mortahty and excess length of stay. Arch Intern Med 148:2642–2645
Rex JH, Bennett, JE, Sugar, AM, et al (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331:1325–1330
Flannagan PG, Barnes RA (1998) Fungal infections in the intensive care unit. J Hosp Infect 38: 163–177
Abies AZ, Blumer, NA, Valainis GT, et al (2000) Fluconazole prophylaxis in trauma and postsurgical patients: a prospective, double blind, randomized palcebo controlled trial. Infect Dis Clin Prac 9:169–175
Pittet D, Munod M, Suter PM, et al (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758
Pittet D, Garbino J (1995) Fungal infections in the critically ill. Curr Opin Crit Care 1:369–380
British society for antimicrobial chemotherapy (1994) Management of deep Candida infections in surgical and intensive care unit patients. Intensive Care Med 20:522–528
Kujaaath P, Lerch K (1989) Secondary mycosis in surgery: treatment with fluconazole. Infection 17:111–117
Eggimann P, Francioli, Bille J, et al (1999) Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27:1066–1072
Hoerauf A, Hammer S, Muller-Myhsok B, Rupprecht H (1998) Intra-abdominal Candida infection during acute necrotizing pancreatitis has a high prevalence and is associated with increased mortality. Crit Care Med 26:2010–2015
Odds FC, Bernaerts RJ (1994) CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. Clin Microbiol 32: 1923–1929
Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758
Chryssanthou E, Andersson B, Petrini B, Lofdahl S, Tollemar J (1994) Detection of Candida albicans DNA in serum by polymerase chain reaction. Scand J Infect Dis 26:479–485
Colombo AL, Barchiesi F, McGough DA, Fothergill AW, Rinaldi MG (1995) Evaluation of the E test system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole. J Antimicrob Chemother 36:93–100
Nozaa Y, Morita T (1986) In: Iwata K, van den Bossche H (eds) In vitro and in vivo evaluation of antifungal agents. Elsevier Science Publishers, Amsterdam, p 111
Nguyen MH, Peacock JE Jr, Morris AJ, et al (1996) The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 100:617–623
Johansen HK, Gøtzsche PC (2000) Amphotericin B vs. fluconazole for controlling fungal infections in neutropenic cancer patients (Cochrane review). In: The Cochrane Library, Issue 3 Update Software, Oxford
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Heslet, L., Mosgaard, F., Tvede, M. (2001). Fungal Infection in Critically III Patients. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 2001. Yearbook of Intensive Care and Emergency Medicine 2001, vol 2001. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59467-0_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-59467-0_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-41407-0
Online ISBN: 978-3-642-59467-0
eBook Packages: Springer Book Archive